US regulator OKs Eisai-Biogen Alzheimer's drug's continuous dosing
TOKYO (Kyodo) -- Japanese pharmaceutical company Eisai Co. and U.S. firm Biogen Inc. said Monday that a jointly developed Alzheimer's drug has been ap
Tomas Kauer - News Moderator 
TOKYO (Kyodo) -- Japanese pharmaceutical company Eisai Co. and U.S. firm Biogen Inc. said Monday that a jointly developed Alzheimer's drug has been ap
